Odylia announced as Amgen Prize finalist for The Odylia Collective

Atlanta, GA, September 10, 2024 —  Innovators in Rare Disease Diagnosis and Care Compete for The Amgen Prize and $150,0000 in Prize Funding at the Concordia Annual Summit Odylia announced as top 5 finalist for the Amgen Prize: Innovation for Patients with Rare Disease. Follow the link...